Cargando…

Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021

The incidence of most respiratory-transmitted diseases decreased during the COVID-19 pandemic as a result of containment measures. In contrast, in the Netherlands we noted an increase in invasive disease caused by Haemophilus influenzae b (Hib) (from < 0.3/100,000 before 2019 to 0.39 and 0.33/100...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steens, Anneke, Stanoeva, Kamelia R, Knol, Mirjam J, Mariman, Rob, de Melker, Hester E, van Sorge, Nina M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532506/ https://www.ncbi.nlm.nih.gov/pubmed/34676819 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.42.2100956

Ejemplares similares

Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands
por: Steens, Anneke, et al.
Publicado: (2022)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020
por: Middeldorp, Marit, et al.
Publicado: (2021)

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Understanding a national increase in COVID-19 vaccination intention, the Netherlands, November 2020–March 2021
por: Sanders, Jet G., et al.
Publicado: (2021)

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021
por: Buil, Jochem B, et al.
Publicado: (2021)

Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021
por: Adlhoch, Cornelia, et al.
Publicado: (2021)

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016
por: Brandwagt, Diederik A. H., et al.
Publicado: (2019)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020
por: Steens, Anneke, et al.
Publicado: (2020)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Temporal cross‐correlation between influenza‐like illnesses and invasive pneumococcal disease in The Netherlands
por: Hendriks, Wilke, et al.
Publicado: (2017)

Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017
por: Russcher, Anne, et al.
Publicado: (2017)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

Lagging Immune Response to Haemophilus influenzae Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
por: Schouls, Leo, et al.
Publicado: (2020)

Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
por: Oreshkova, Nadia, et al.
Publicado: (2020)

First autochthonous human West Nile virus infections in the Netherlands, July to August 2020
por: Vlaskamp, Danique RM, et al.
Publicado: (2020)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Detection of West Nile virus in a common whitethroat (Curruca communis) and Culex mosquitoes in the Netherlands, 2020
por: Sikkema, Reina S, et al.
Publicado: (2020)

Misidentification of meticillin-resistant Staphylococcus aureus by the Cepheid Xpert MRSA NxG assay, the Netherlands, February to March 2021
por: Sabat, Artur J, et al.
Publicado: (2021)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020
por: de Gier, Brechje, et al.
Publicado: (2020)

Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2021)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018
por: Meijer, Adam, et al.
Publicado: (2018)

Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021
por: Molenkamp, Richard, et al.
Publicado: (2021)

Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020
por: Reusken, Chantal B, et al.
Publicado: (2020)

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
por: van Ewijk, Catharina E, et al.
Publicado: (2022)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

The silent epidemic of lymphogranuloma venereum inside the COVID-19 pandemic in Madrid, Spain, March 2020 to February 2021
por: Martínez-García, Laura, et al.
Publicado: (2021)

Molecular epidemiology and antibiotic resistance profiles of invasive Haemophilus influenzae from Norway 2017–2021
por: Tønnessen, Ragnhild, et al.
Publicado: (2022)

Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021
por: Backer, Jantien A, et al.
Publicado: (2022)

Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020
por: Tostmann, Alma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u53nfbave9488saakv60gj8ja8